杨坡, 吴杰, 路粉, 赵建江, 毕秋艳, 韩秀英, 李洋, 王文桥. 致病疫霉对缬菌胺敏感基线的建立及抗性风险评估[J]. 农药学学报, 2022, 24(3): 474-482. DOI: 10.16801/j.issn.1008-7303.2021.0171
    引用本文: 杨坡, 吴杰, 路粉, 赵建江, 毕秋艳, 韩秀英, 李洋, 王文桥. 致病疫霉对缬菌胺敏感基线的建立及抗性风险评估[J]. 农药学学报, 2022, 24(3): 474-482. DOI: 10.16801/j.issn.1008-7303.2021.0171
    YANG Po, WU Jie, LU Fen, ZHAO Jianjiang, BI Qiuyan, HAN Xiuying, LI Yang, WANG Wenqiao. Establishment of sensitivity baseline of Phytophthora infestans to valifenalate and risk assessment of resistance[J]. Chinese Journal of Pesticide Science, 2022, 24(3): 474-482. DOI: 10.16801/j.issn.1008-7303.2021.0171
    Citation: YANG Po, WU Jie, LU Fen, ZHAO Jianjiang, BI Qiuyan, HAN Xiuying, LI Yang, WANG Wenqiao. Establishment of sensitivity baseline of Phytophthora infestans to valifenalate and risk assessment of resistance[J]. Chinese Journal of Pesticide Science, 2022, 24(3): 474-482. DOI: 10.16801/j.issn.1008-7303.2021.0171

    致病疫霉对缬菌胺敏感基线的建立及抗性风险评估

    Establishment of sensitivity baseline of Phytophthora infestans to valifenalate and risk assessment of resistance

    • 摘要: 为建立致病疫霉Phytophthora infestans (Mont.) de Bary对缬菌胺的敏感基线,采用菌丝生长速率法测定了从河北省、黑龙江省、内蒙古自治区、贵州省和四川省未使用过缬菌胺的地区采集分离的105个致病疫霉菌株对缬菌胺的敏感性;为明确致病疫霉对缬菌胺产生抗性突变体的难易程度,进行了紫外诱导和药剂驯化试验;为明确缬菌胺与常用药剂之间的交互抗性,测定了8个抗缬菌胺突变体及其6个亲本敏感菌株对6种常用杀菌剂的敏感性。结果表明:105株致病疫霉对缬菌胺的EC50值范围为0.0594~0.159 mg/L,平均EC50值为(0.102 ± 0.024) mg/L,不同敏感性菌株的频率呈连续单峰曲线分布,未发现敏感性下降的亚群体,因此可将缬菌胺对105株致病疫霉的平均EC50值作为致病疫霉对缬菌胺的敏感基线;通过紫外诱变敏感菌株菌丝体获得了4个抗缬菌胺的突变体,其抗性水平介于 3.1~14.9倍之间,突变频率为0.54%,通过紫外照射敏感菌株孢子囊悬浮液获得了2个抗性水平分别为8.1倍和8.2倍的抗性突变体,突变频率为1.33 × 10−7;通过在含缬菌胺的黑麦蔗糖琼脂培养基上继代培养敏感菌株11代,获得2个抗性水平分别为3.1倍和9.4倍的抗性突变体。缬菌胺与烯酰吗啉和双炔酰菌胺存在交互抗性,与氟吡菌胺、嘧菌酯、甲霜灵和霜脲氰不存在交互抗性。初步推测致病疫霉对缬菌胺具有低到中等抗性风险,建议在生产上将缬菌胺与其他类型杀菌剂交替或混合使用,以延缓致病疫霉对缬菌胺抗性的产生。

       

      Abstract: In order to establish the baseline sensitivity of Phytophthora infestans (Mont.) de Bary to valifenalate, the sensitivities to valifenalate of 105 P.infestans isolates collected from Hebei, Heilongjiang, Guizhou, Sichuan and Inner Mongolia Autonomous Region, where valifenalate had never been used,were determined by mycelial growth rate method. To clarify the difficulty degree of acquisition of valifenalate-resistant mutants in P. infestans, UV mutagensis and fungicide adaptation test were conducted. In order to clarify the patterns of cross-resistance between valifenalate and fungicides regularly used for late blight control, the sensitivities to valifenalate and six fungicides of eight resistant mutants and their six parent sensitive strains were tested. The results showed that the EC50 values ranged from 0.0594 mg/L to 0.159 mg/L and the mean EC50 value of 105 isolates was (0.102±0.024) mg/L. The frequency of sensitivity to valifenalate distributed as a unimodal curve, and there was no subgroup with sensitivity declined, so the mean EC50 value could be regarded as the sensitivity baseline to valifenalate in P. infestans. Four mutants resistant to valifenalate with the resistance factors ranging from 3.2 to 14.9 were obtained through UV-irradiating mycelia of strains sensitive to valifenalate and the resistance mutagenesis frequency was 0.54%. Two mutants resistant with the resistance factors of 8.1 and 8.2 were obtained through UV-irradiating sporangia of strains sensitive to valifenalate and the resistance mutagenesis frequency was 1.33 × 10−7. Two mutants resistant to valifenalate with the resistance factors from 3.1 and 9.4 were obtained through 11 generation subcultures. No cross resistance relationship existed between valifenalate and azoxystrobin or fluopicolide or metalaxyl or cymoxanil, but cross resistance existed between valifenalate and mandipropamid or dimethomorph. It was suggested that P. infestans could have a low to moderate resistance risk to valifenalate. Therefore, valifenalate should be used for late blight in mixtures or rotation with other fungicides of different action mechanisms in production to avoid or delay the buildup of valifenalate resistance in P. infestans.

       

    /

    返回文章
    返回